- Home
- NIU vs PYXS Comparison
NIU vs PYXS Comparison
Compare NIU & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NIU | PYXS |
|---|---|---|
| Founded | 2014 | 2018 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.6M | 243.5M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NIU | PYXS |
|---|---|---|
| Price | $3.27 | $4.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 595.8K | ★ 683.6K |
| Earning Date | 11-17-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $625,182,280.00 | $2,820,000.00 |
| Revenue This Year | $42.51 | N/A |
| Revenue Next Year | $23.71 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 50.99 | N/A |
| 52 Week Low | $1.66 | $0.83 |
| 52 Week High | $5.67 | $5.55 |
Technical Indicators
Market Signals| Indicator | NIU | PYXS |
|---|---|---|
| Relative Strength Index (RSI) | 38.66 | 47.85 |
| Support Level | $3.14 | $4.10 |
| Resistance Level | $3.31 | $4.35 |
| Average True Range (ATR) | 0.16 | 0.39 |
| MACD | 0.00 | -0.12 |
| Stochastic Oscillator | 27.59 | 26.60 |
Price Performance
Historical ComparisonAbout NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.